nodes	percent_of_prediction	percent_of_DWPC	metapath
Dasatinib—CYP1B1—Dexamethasone—ankylosing spondylitis	0.0652	0.148	CbGbCtD
Dasatinib—ABCG2—Sulfasalazine—ankylosing spondylitis	0.0621	0.141	CbGbCtD
Dasatinib—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.0344	0.0781	CbGbCtD
Dasatinib—ABCG2—Dexamethasone—ankylosing spondylitis	0.031	0.0703	CbGbCtD
Dasatinib—SRMS—knee—ankylosing spondylitis	0.0298	0.361	CbGeAlD
Dasatinib—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0295	0.0671	CbGbCtD
Dasatinib—CYP1A1—Dexamethasone—ankylosing spondylitis	0.0286	0.0649	CbGbCtD
Dasatinib—ABCG2—Methotrexate—ankylosing spondylitis	0.0249	0.0565	CbGbCtD
Dasatinib—ABCB1—Betamethasone—ankylosing spondylitis	0.0192	0.0436	CbGbCtD
Dasatinib—ABCB1—Prednisolone—ankylosing spondylitis	0.019	0.043	CbGbCtD
Dasatinib—ABCB1—Prednisone—ankylosing spondylitis	0.0179	0.0406	CbGbCtD
Dasatinib—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0177	0.0402	CbGbCtD
Dasatinib—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0172	0.039	CbGbCtD
Dasatinib—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0134	0.0304	CbGbCtD
Dasatinib—CYP3A4—Betamethasone—ankylosing spondylitis	0.0115	0.0261	CbGbCtD
Dasatinib—CYP3A4—Prednisolone—ankylosing spondylitis	0.0114	0.0258	CbGbCtD
Dasatinib—ABCB1—Dexamethasone—ankylosing spondylitis	0.0112	0.0254	CbGbCtD
Dasatinib—CYP3A4—Prednisone—ankylosing spondylitis	0.0107	0.0243	CbGbCtD
Dasatinib—RIPK2—synovial membrane of synovial joint—ankylosing spondylitis	0.00946	0.115	CbGeAlD
Dasatinib—ABCB1—Methotrexate—ankylosing spondylitis	0.00898	0.0204	CbGbCtD
Dasatinib—CYP3A4—Dexamethasone—ankylosing spondylitis	0.00669	0.0152	CbGbCtD
Dasatinib—TEC—tendon—ankylosing spondylitis	0.0039	0.0472	CbGeAlD
Dasatinib—EPHB1—tendon—ankylosing spondylitis	0.00306	0.037	CbGeAlD
Dasatinib—SIK3—tendon—ankylosing spondylitis	0.00205	0.0248	CbGeAlD
Dasatinib—ZAK—tendon—ankylosing spondylitis	0.0019	0.0231	CbGeAlD
Dasatinib—BTK—tendon—ankylosing spondylitis	0.00182	0.022	CbGeAlD
Dasatinib—TESK1—tendon—ankylosing spondylitis	0.00168	0.0204	CbGeAlD
Dasatinib—STK36—tendon—ankylosing spondylitis	0.00166	0.0201	CbGeAlD
Dasatinib—STK35—tendon—ankylosing spondylitis	0.00155	0.0188	CbGeAlD
Dasatinib—CSK—tendon—ankylosing spondylitis	0.00154	0.0187	CbGeAlD
Dasatinib—HCK—tendon—ankylosing spondylitis	0.00152	0.0184	CbGeAlD
Dasatinib—ABL2—tendon—ankylosing spondylitis	0.00151	0.0183	CbGeAlD
Dasatinib—RIPK2—tendon—ankylosing spondylitis	0.00143	0.0173	CbGeAlD
Dasatinib—SIK1—tendon—ankylosing spondylitis	0.0014	0.0169	CbGeAlD
Dasatinib—EPHA4—tendon—ankylosing spondylitis	0.00138	0.0168	CbGeAlD
Dasatinib—MAPK14—tendon—ankylosing spondylitis	0.00128	0.0154	CbGeAlD
Dasatinib—FGR—tendon—ankylosing spondylitis	0.00127	0.0154	CbGeAlD
Dasatinib—EPHB4—tendon—ankylosing spondylitis	0.00121	0.0146	CbGeAlD
Dasatinib—JAK2—tendon—ankylosing spondylitis	0.0012	0.0145	CbGeAlD
Dasatinib—EPHA2—tendon—ankylosing spondylitis	0.00119	0.0144	CbGeAlD
Dasatinib—FYN—tendon—ankylosing spondylitis	0.00118	0.0143	CbGeAlD
Dasatinib—MAP4K5—tendon—ankylosing spondylitis	0.00116	0.014	CbGeAlD
Dasatinib—MAP3K3—tendon—ankylosing spondylitis	0.00116	0.014	CbGeAlD
Dasatinib—EPHB6—tendon—ankylosing spondylitis	0.00111	0.0134	CbGeAlD
Dasatinib—YES1—tendon—ankylosing spondylitis	0.00107	0.0129	CbGeAlD
Dasatinib—PDGFRA—tendon—ankylosing spondylitis	0.00105	0.0127	CbGeAlD
Dasatinib—MAP2K5—tendon—ankylosing spondylitis	0.000946	0.0115	CbGeAlD
Dasatinib—CSF1R—tendon—ankylosing spondylitis	0.000923	0.0112	CbGeAlD
Dasatinib—PDGFRB—tendon—ankylosing spondylitis	0.000819	0.00991	CbGeAlD
Dasatinib—EPHB2—Diflorasone—Methylprednisolone—ankylosing spondylitis	0.000807	0.0989	CbGdCrCtD
Dasatinib—EPHB2—Diflorasone—Dexamethasone—ankylosing spondylitis	0.000794	0.0973	CbGdCrCtD
Dasatinib—EPHB2—Diflorasone—Betamethasone—ankylosing spondylitis	0.000794	0.0973	CbGdCrCtD
Dasatinib—EPHB2—Diflorasone—Triamcinolone—ankylosing spondylitis	0.000776	0.0951	CbGdCrCtD
Dasatinib—EPHB2—Diflorasone—Prednisone—ankylosing spondylitis	0.000736	0.0902	CbGdCrCtD
Dasatinib—ABL1—tendon—ankylosing spondylitis	0.00073	0.00883	CbGeAlD
Dasatinib—EPHB2—Diflorasone—Prednisolone—ankylosing spondylitis	0.000719	0.0881	CbGdCrCtD
Dasatinib—CYP1B1—tendon—ankylosing spondylitis	0.000618	0.00748	CbGeAlD
Dasatinib—PKMYT1—Danazol—Prednisone—ankylosing spondylitis	0.000418	0.0512	CbGdCrCtD
Dasatinib—TESK1—Dexamethasone—Methylprednisolone—ankylosing spondylitis	0.000328	0.0402	CbGdCrCtD
Dasatinib—TESK1—Betamethasone—Methylprednisolone—ankylosing spondylitis	0.000328	0.0402	CbGdCrCtD
Dasatinib—TESK1—Betamethasone—Dexamethasone—ankylosing spondylitis	0.000323	0.0396	CbGdCrCtD
Dasatinib—TESK1—Dexamethasone—Betamethasone—ankylosing spondylitis	0.000323	0.0396	CbGdCrCtD
Dasatinib—TESK1—Betamethasone—Triamcinolone—ankylosing spondylitis	0.000315	0.0386	CbGdCrCtD
Dasatinib—TESK1—Dexamethasone—Triamcinolone—ankylosing spondylitis	0.000315	0.0386	CbGdCrCtD
Dasatinib—TESK1—Dexamethasone—Prednisone—ankylosing spondylitis	0.000299	0.0367	CbGdCrCtD
Dasatinib—TESK1—Betamethasone—Prednisone—ankylosing spondylitis	0.000299	0.0367	CbGdCrCtD
Dasatinib—TESK1—Betamethasone—Prednisolone—ankylosing spondylitis	0.000292	0.0358	CbGdCrCtD
Dasatinib—TESK1—Dexamethasone—Prednisolone—ankylosing spondylitis	0.000292	0.0358	CbGdCrCtD
Dasatinib—Malaise—Betamethasone—ankylosing spondylitis	0.000254	0.00109	CcSEcCtD
Dasatinib—Malaise—Dexamethasone—ankylosing spondylitis	0.000254	0.00109	CcSEcCtD
Dasatinib—Oedema—Triamcinolone—ankylosing spondylitis	0.000253	0.00108	CcSEcCtD
Dasatinib—Vertigo—Dexamethasone—ankylosing spondylitis	0.000253	0.00108	CcSEcCtD
Dasatinib—Vertigo—Betamethasone—ankylosing spondylitis	0.000253	0.00108	CcSEcCtD
Dasatinib—Syncope—Betamethasone—ankylosing spondylitis	0.000252	0.00108	CcSEcCtD
Dasatinib—Syncope—Dexamethasone—ankylosing spondylitis	0.000252	0.00108	CcSEcCtD
Dasatinib—Arrhythmia—Prednisone—ankylosing spondylitis	0.000252	0.00108	CcSEcCtD
Dasatinib—Infection—Triamcinolone—ankylosing spondylitis	0.000252	0.00108	CcSEcCtD
Dasatinib—Infection—Methylprednisolone—ankylosing spondylitis	0.000251	0.00107	CcSEcCtD
Dasatinib—Haematuria—Methotrexate—ankylosing spondylitis	0.00025	0.00107	CcSEcCtD
Dasatinib—Shock—Triamcinolone—ankylosing spondylitis	0.000249	0.00107	CcSEcCtD
Dasatinib—Insomnia—Prednisolone—ankylosing spondylitis	0.000249	0.00107	CcSEcCtD
Dasatinib—Alopecia—Prednisone—ankylosing spondylitis	0.000249	0.00106	CcSEcCtD
Dasatinib—Shock—Methylprednisolone—ankylosing spondylitis	0.000249	0.00106	CcSEcCtD
Dasatinib—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000248	0.00106	CcSEcCtD
Dasatinib—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000248	0.00106	CcSEcCtD
Dasatinib—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000247	0.00106	CcSEcCtD
Dasatinib—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000247	0.00106	CcSEcCtD
Dasatinib—Epistaxis—Methotrexate—ankylosing spondylitis	0.000247	0.00106	CcSEcCtD
Dasatinib—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000247	0.00106	CcSEcCtD
Dasatinib—Mental disorder—Prednisone—ankylosing spondylitis	0.000247	0.00106	CcSEcCtD
Dasatinib—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000247	0.00105	CcSEcCtD
Dasatinib—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000245	0.00105	CcSEcCtD
Dasatinib—Malnutrition—Prednisone—ankylosing spondylitis	0.000245	0.00105	CcSEcCtD
Dasatinib—Erythema—Prednisone—ankylosing spondylitis	0.000245	0.00105	CcSEcCtD
Dasatinib—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000245	0.00105	CcSEcCtD
Dasatinib—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000244	0.00104	CcSEcCtD
Dasatinib—Convulsion—Betamethasone—ankylosing spondylitis	0.000244	0.00104	CcSEcCtD
Dasatinib—Convulsion—Dexamethasone—ankylosing spondylitis	0.000244	0.00104	CcSEcCtD
Dasatinib—Hypertension—Betamethasone—ankylosing spondylitis	0.000243	0.00104	CcSEcCtD
Dasatinib—Hypertension—Dexamethasone—ankylosing spondylitis	0.000243	0.00104	CcSEcCtD
Dasatinib—Myalgia—Dexamethasone—ankylosing spondylitis	0.00024	0.00102	CcSEcCtD
Dasatinib—Myalgia—Betamethasone—ankylosing spondylitis	0.00024	0.00102	CcSEcCtD
Dasatinib—Anxiety—Dexamethasone—ankylosing spondylitis	0.000239	0.00102	CcSEcCtD
Dasatinib—Anxiety—Betamethasone—ankylosing spondylitis	0.000239	0.00102	CcSEcCtD
Dasatinib—Discomfort—Betamethasone—ankylosing spondylitis	0.000237	0.00101	CcSEcCtD
Dasatinib—Discomfort—Dexamethasone—ankylosing spondylitis	0.000237	0.00101	CcSEcCtD
Dasatinib—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000237	0.00101	CcSEcCtD
Dasatinib—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000236	0.00101	CcSEcCtD
Dasatinib—Pain—Prednisolone—ankylosing spondylitis	0.000235	0.00101	CcSEcCtD
Dasatinib—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000235	0.00101	CcSEcCtD
Dasatinib—Hepatitis—Methotrexate—ankylosing spondylitis	0.000235	0.00101	CcSEcCtD
Dasatinib—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000232	0.000994	CcSEcCtD
Dasatinib—Vision blurred—Prednisone—ankylosing spondylitis	0.000231	0.000988	CcSEcCtD
Dasatinib—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000231	0.000987	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000231	0.000987	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00023	0.000984	CcSEcCtD
Dasatinib—Oedema—Dexamethasone—ankylosing spondylitis	0.00023	0.000983	CcSEcCtD
Dasatinib—Oedema—Betamethasone—ankylosing spondylitis	0.00023	0.000983	CcSEcCtD
Dasatinib—Insomnia—Triamcinolone—ankylosing spondylitis	0.000229	0.000979	CcSEcCtD
Dasatinib—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000228	0.000977	CcSEcCtD
Dasatinib—Infection—Dexamethasone—ankylosing spondylitis	0.000228	0.000976	CcSEcCtD
Dasatinib—Infection—Betamethasone—ankylosing spondylitis	0.000228	0.000976	CcSEcCtD
Dasatinib—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000227	0.000973	CcSEcCtD
Dasatinib—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000227	0.00097	CcSEcCtD
Dasatinib—Visual impairment—Methotrexate—ankylosing spondylitis	0.000227	0.00097	CcSEcCtD
Dasatinib—Anaemia—Prednisone—ankylosing spondylitis	0.000227	0.000969	CcSEcCtD
Dasatinib—Shock—Dexamethasone—ankylosing spondylitis	0.000226	0.000967	CcSEcCtD
Dasatinib—Shock—Betamethasone—ankylosing spondylitis	0.000226	0.000967	CcSEcCtD
Dasatinib—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000226	0.000965	CcSEcCtD
Dasatinib—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000225	0.000964	CcSEcCtD
Dasatinib—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000225	0.000964	CcSEcCtD
Dasatinib—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000225	0.000962	CcSEcCtD
Dasatinib—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000225	0.000962	CcSEcCtD
Dasatinib—Tachycardia—Betamethasone—ankylosing spondylitis	0.000224	0.000959	CcSEcCtD
Dasatinib—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000224	0.000959	CcSEcCtD
Dasatinib—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000223	0.000953	CcSEcCtD
Dasatinib—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000223	0.000952	CcSEcCtD
Dasatinib—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000222	0.000951	CcSEcCtD
Dasatinib—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000222	0.00095	CcSEcCtD
Dasatinib—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000222	0.00095	CcSEcCtD
Dasatinib—Malaise—Prednisone—ankylosing spondylitis	0.000221	0.000945	CcSEcCtD
Dasatinib—Vertigo—Prednisone—ankylosing spondylitis	0.00022	0.000942	CcSEcCtD
Dasatinib—Eye disorder—Methotrexate—ankylosing spondylitis	0.00022	0.000941	CcSEcCtD
Dasatinib—Syncope—Prednisone—ankylosing spondylitis	0.00022	0.00094	CcSEcCtD
Dasatinib—Tinnitus—Methotrexate—ankylosing spondylitis	0.000219	0.000938	CcSEcCtD
Dasatinib—Anorexia—Betamethasone—ankylosing spondylitis	0.000219	0.000937	CcSEcCtD
Dasatinib—Anorexia—Dexamethasone—ankylosing spondylitis	0.000219	0.000937	CcSEcCtD
Dasatinib—Urticaria—Prednisolone—ankylosing spondylitis	0.000219	0.000935	CcSEcCtD
Dasatinib—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000218	0.000934	CcSEcCtD
Dasatinib—Fatigue—Triamcinolone—ankylosing spondylitis	0.000218	0.000934	CcSEcCtD
Dasatinib—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000218	0.000932	CcSEcCtD
Dasatinib—Pain—Triamcinolone—ankylosing spondylitis	0.000216	0.000926	CcSEcCtD
Dasatinib—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000215	0.000922	CcSEcCtD
Dasatinib—Hypotension—Dexamethasone—ankylosing spondylitis	0.000215	0.000918	CcSEcCtD
Dasatinib—Hypotension—Betamethasone—ankylosing spondylitis	0.000215	0.000918	CcSEcCtD
Dasatinib—Angiopathy—Methotrexate—ankylosing spondylitis	0.000214	0.000913	CcSEcCtD
Dasatinib—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000213	0.000909	CcSEcCtD
Dasatinib—Convulsion—Prednisone—ankylosing spondylitis	0.000212	0.000908	CcSEcCtD
Dasatinib—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000212	0.000907	CcSEcCtD
Dasatinib—Hypertension—Prednisone—ankylosing spondylitis	0.000212	0.000905	CcSEcCtD
Dasatinib—Chills—Methotrexate—ankylosing spondylitis	0.000211	0.000903	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000209	0.000895	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000209	0.000895	CcSEcCtD
Dasatinib—Myalgia—Prednisone—ankylosing spondylitis	0.000209	0.000893	CcSEcCtD
Dasatinib—Arthralgia—Prednisone—ankylosing spondylitis	0.000209	0.000893	CcSEcCtD
Dasatinib—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000209	0.000892	CcSEcCtD
Dasatinib—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000208	0.00089	CcSEcCtD
Dasatinib—Anxiety—Prednisone—ankylosing spondylitis	0.000208	0.00089	CcSEcCtD
Dasatinib—Alopecia—Methotrexate—ankylosing spondylitis	0.000208	0.000889	CcSEcCtD
Dasatinib—Insomnia—Betamethasone—ankylosing spondylitis	0.000208	0.000889	CcSEcCtD
Dasatinib—Insomnia—Dexamethasone—ankylosing spondylitis	0.000208	0.000889	CcSEcCtD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000207	0.000886	CcSEcCtD
Dasatinib—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000207	0.000884	CcSEcCtD
Dasatinib—Discomfort—Prednisone—ankylosing spondylitis	0.000206	0.000882	CcSEcCtD
Dasatinib—Mental disorder—Methotrexate—ankylosing spondylitis	0.000206	0.000882	CcSEcCtD
Dasatinib—Malnutrition—Methotrexate—ankylosing spondylitis	0.000205	0.000876	CcSEcCtD
Dasatinib—Erythema—Methotrexate—ankylosing spondylitis	0.000205	0.000876	CcSEcCtD
Dasatinib—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000203	0.000868	CcSEcCtD
Dasatinib—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000202	0.000865	CcSEcCtD
Dasatinib—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000202	0.000865	CcSEcCtD
Dasatinib—Urticaria—Triamcinolone—ankylosing spondylitis	0.000201	0.00086	CcSEcCtD
Dasatinib—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000201	0.000858	CcSEcCtD
Dasatinib—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000201	0.000858	CcSEcCtD
Dasatinib—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.0002	0.000856	CcSEcCtD
Dasatinib—Oedema—Prednisone—ankylosing spondylitis	0.0002	0.000856	CcSEcCtD
Dasatinib—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.0002	0.000854	CcSEcCtD
Dasatinib—Decreased appetite—Betamethasone—ankylosing spondylitis	0.0002	0.000854	CcSEcCtD
Dasatinib—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.0002	0.000854	CcSEcCtD
Dasatinib—Infection—Prednisone—ankylosing spondylitis	0.000199	0.00085	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000198	0.000848	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000198	0.000848	CcSEcCtD
Dasatinib—Fatigue—Betamethasone—ankylosing spondylitis	0.000198	0.000847	CcSEcCtD
Dasatinib—Fatigue—Dexamethasone—ankylosing spondylitis	0.000198	0.000847	CcSEcCtD
Dasatinib—Shock—Prednisone—ankylosing spondylitis	0.000197	0.000842	CcSEcCtD
Dasatinib—Pain—Betamethasone—ankylosing spondylitis	0.000196	0.00084	CcSEcCtD
Dasatinib—Pain—Dexamethasone—ankylosing spondylitis	0.000196	0.00084	CcSEcCtD
Dasatinib—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000196	0.000839	CcSEcCtD
Dasatinib—Tachycardia—Prednisone—ankylosing spondylitis	0.000195	0.000835	CcSEcCtD
Dasatinib—Skin disorder—Prednisone—ankylosing spondylitis	0.000194	0.000831	CcSEcCtD
Dasatinib—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000193	0.000827	CcSEcCtD
Dasatinib—Vision blurred—Methotrexate—ankylosing spondylitis	0.000193	0.000826	CcSEcCtD
Dasatinib—Anorexia—Prednisone—ankylosing spondylitis	0.000191	0.000816	CcSEcCtD
Dasatinib—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.00019	0.000813	CcSEcCtD
Dasatinib—Anaemia—Methotrexate—ankylosing spondylitis	0.000189	0.00081	CcSEcCtD
Dasatinib—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000189	0.00081	CcSEcCtD
Dasatinib—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000189	0.00081	CcSEcCtD
Dasatinib—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000188	0.000803	CcSEcCtD
Dasatinib—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000188	0.000803	CcSEcCtD
Dasatinib—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000187	0.000798	CcSEcCtD
Dasatinib—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000186	0.000796	CcSEcCtD
Dasatinib—Malaise—Methotrexate—ankylosing spondylitis	0.000185	0.00079	CcSEcCtD
Dasatinib—Vertigo—Methotrexate—ankylosing spondylitis	0.000184	0.000787	CcSEcCtD
Dasatinib—Urticaria—Betamethasone—ankylosing spondylitis	0.000182	0.000781	CcSEcCtD
Dasatinib—Urticaria—Dexamethasone—ankylosing spondylitis	0.000182	0.000781	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000182	0.00078	CcSEcCtD
Dasatinib—Dizziness—Prednisolone—ankylosing spondylitis	0.000182	0.000779	CcSEcCtD
Dasatinib—Asthenia—Triamcinolone—ankylosing spondylitis	0.000182	0.000777	CcSEcCtD
Dasatinib—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000182	0.000777	CcSEcCtD
Dasatinib—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000182	0.000777	CcSEcCtD
Dasatinib—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000182	0.000777	CcSEcCtD
Dasatinib—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000182	0.000777	CcSEcCtD
Dasatinib—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000181	0.000775	CcSEcCtD
Dasatinib—Insomnia—Prednisone—ankylosing spondylitis	0.000181	0.000774	CcSEcCtD
Dasatinib—Pruritus—Triamcinolone—ankylosing spondylitis	0.000179	0.000766	CcSEcCtD
Dasatinib—Cough—Methotrexate—ankylosing spondylitis	0.000179	0.000765	CcSEcCtD
Dasatinib—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000179	0.000764	CcSEcCtD
Dasatinib—Convulsion—Methotrexate—ankylosing spondylitis	0.000177	0.000759	CcSEcCtD
Dasatinib—Dyspepsia—Prednisone—ankylosing spondylitis	0.000176	0.000753	CcSEcCtD
Dasatinib—Myalgia—Methotrexate—ankylosing spondylitis	0.000174	0.000746	CcSEcCtD
Dasatinib—Chest pain—Methotrexate—ankylosing spondylitis	0.000174	0.000746	CcSEcCtD
Dasatinib—Arthralgia—Methotrexate—ankylosing spondylitis	0.000174	0.000746	CcSEcCtD
Dasatinib—Decreased appetite—Prednisone—ankylosing spondylitis	0.000174	0.000744	CcSEcCtD
Dasatinib—Rash—Prednisolone—ankylosing spondylitis	0.000174	0.000742	CcSEcCtD
Dasatinib—Dermatitis—Prednisolone—ankylosing spondylitis	0.000173	0.000742	CcSEcCtD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000173	0.000741	CcSEcCtD
Dasatinib—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000173	0.000739	CcSEcCtD
Dasatinib—Fatigue—Prednisone—ankylosing spondylitis	0.000172	0.000738	CcSEcCtD
Dasatinib—Headache—Prednisolone—ankylosing spondylitis	0.000172	0.000738	CcSEcCtD
Dasatinib—Discomfort—Methotrexate—ankylosing spondylitis	0.000172	0.000737	CcSEcCtD
Dasatinib—Constipation—Prednisone—ankylosing spondylitis	0.000171	0.000732	CcSEcCtD
Dasatinib—Confusional state—Methotrexate—ankylosing spondylitis	0.000169	0.000721	CcSEcCtD
Dasatinib—Dizziness—Triamcinolone—ankylosing spondylitis	0.000167	0.000716	CcSEcCtD
Dasatinib—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000167	0.000714	CcSEcCtD
Dasatinib—Infection—Methotrexate—ankylosing spondylitis	0.000166	0.00071	CcSEcCtD
Dasatinib—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000165	0.000705	CcSEcCtD
Dasatinib—Asthenia—Dexamethasone—ankylosing spondylitis	0.000165	0.000705	CcSEcCtD
Dasatinib—Asthenia—Betamethasone—ankylosing spondylitis	0.000165	0.000705	CcSEcCtD
Dasatinib—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000164	0.000701	CcSEcCtD
Dasatinib—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000164	0.0007	CcSEcCtD
Dasatinib—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000164	0.0007	CcSEcCtD
Dasatinib—Nausea—Prednisolone—ankylosing spondylitis	0.000164	0.000699	CcSEcCtD
Dasatinib—Pruritus—Dexamethasone—ankylosing spondylitis	0.000163	0.000695	CcSEcCtD
Dasatinib—Pruritus—Betamethasone—ankylosing spondylitis	0.000163	0.000695	CcSEcCtD
Dasatinib—Skin disorder—Methotrexate—ankylosing spondylitis	0.000162	0.000695	CcSEcCtD
Dasatinib—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000162	0.000691	CcSEcCtD
Dasatinib—Vomiting—Triamcinolone—ankylosing spondylitis	0.000161	0.000689	CcSEcCtD
Dasatinib—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000161	0.000687	CcSEcCtD
Dasatinib—Rash—Triamcinolone—ankylosing spondylitis	0.00016	0.000683	CcSEcCtD
Dasatinib—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000159	0.000682	CcSEcCtD
Dasatinib—Anorexia—Methotrexate—ankylosing spondylitis	0.000159	0.000682	CcSEcCtD
Dasatinib—Rash—Methylprednisolone—ankylosing spondylitis	0.000159	0.000681	CcSEcCtD
Dasatinib—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000159	0.000681	CcSEcCtD
Dasatinib—Urticaria—Prednisone—ankylosing spondylitis	0.000159	0.00068	CcSEcCtD
Dasatinib—Headache—Triamcinolone—ankylosing spondylitis	0.000159	0.000678	CcSEcCtD
Dasatinib—Headache—Methylprednisolone—ankylosing spondylitis	0.000158	0.000677	CcSEcCtD
Dasatinib—Abdominal pain—Prednisone—ankylosing spondylitis	0.000158	0.000676	CcSEcCtD
Dasatinib—Body temperature increased—Prednisone—ankylosing spondylitis	0.000158	0.000676	CcSEcCtD
Dasatinib—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000157	0.000672	CcSEcCtD
Dasatinib—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000157	0.000672	CcSEcCtD
Dasatinib—Hypotension—Methotrexate—ankylosing spondylitis	0.000156	0.000668	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000152	0.000652	CcSEcCtD
Dasatinib—Dizziness—Dexamethasone—ankylosing spondylitis	0.000152	0.00065	CcSEcCtD
Dasatinib—Dizziness—Betamethasone—ankylosing spondylitis	0.000152	0.00065	CcSEcCtD
Dasatinib—Insomnia—Methotrexate—ankylosing spondylitis	0.000151	0.000647	CcSEcCtD
Dasatinib—Nausea—Triamcinolone—ankylosing spondylitis	0.00015	0.000643	CcSEcCtD
Dasatinib—Nausea—Methylprednisolone—ankylosing spondylitis	0.00015	0.000642	CcSEcCtD
Dasatinib—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000149	0.000638	CcSEcCtD
Dasatinib—Somnolence—Methotrexate—ankylosing spondylitis	0.000149	0.000636	CcSEcCtD
Dasatinib—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000147	0.00063	CcSEcCtD
Dasatinib—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000147	0.000629	CcSEcCtD
Dasatinib—Vomiting—Betamethasone—ankylosing spondylitis	0.000146	0.000625	CcSEcCtD
Dasatinib—Vomiting—Dexamethasone—ankylosing spondylitis	0.000146	0.000625	CcSEcCtD
Dasatinib—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000145	0.000622	CcSEcCtD
Dasatinib—Rash—Dexamethasone—ankylosing spondylitis	0.000145	0.00062	CcSEcCtD
Dasatinib—Rash—Betamethasone—ankylosing spondylitis	0.000145	0.00062	CcSEcCtD
Dasatinib—Dermatitis—Betamethasone—ankylosing spondylitis	0.000145	0.000619	CcSEcCtD
Dasatinib—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000145	0.000619	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000144	0.000617	CcSEcCtD
Dasatinib—Fatigue—Methotrexate—ankylosing spondylitis	0.000144	0.000617	CcSEcCtD
Dasatinib—Headache—Dexamethasone—ankylosing spondylitis	0.000144	0.000616	CcSEcCtD
Dasatinib—Headache—Betamethasone—ankylosing spondylitis	0.000144	0.000616	CcSEcCtD
Dasatinib—Asthenia—Prednisone—ankylosing spondylitis	0.000144	0.000614	CcSEcCtD
Dasatinib—Pain—Methotrexate—ankylosing spondylitis	0.000143	0.000612	CcSEcCtD
Dasatinib—Pruritus—Prednisone—ankylosing spondylitis	0.000142	0.000605	CcSEcCtD
Dasatinib—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000138	0.000589	CcSEcCtD
Dasatinib—Diarrhoea—Prednisone—ankylosing spondylitis	0.000137	0.000585	CcSEcCtD
Dasatinib—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000137	0.000585	CcSEcCtD
Dasatinib—Nausea—Betamethasone—ankylosing spondylitis	0.000136	0.000584	CcSEcCtD
Dasatinib—Nausea—Dexamethasone—ankylosing spondylitis	0.000136	0.000584	CcSEcCtD
Dasatinib—Urticaria—Methotrexate—ankylosing spondylitis	0.000133	0.000568	CcSEcCtD
Dasatinib—Dizziness—Prednisone—ankylosing spondylitis	0.000132	0.000566	CcSEcCtD
Dasatinib—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000132	0.000565	CcSEcCtD
Dasatinib—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000132	0.000565	CcSEcCtD
Dasatinib—Vomiting—Prednisone—ankylosing spondylitis	0.000127	0.000544	CcSEcCtD
Dasatinib—Rash—Prednisone—ankylosing spondylitis	0.000126	0.00054	CcSEcCtD
Dasatinib—Dermatitis—Prednisone—ankylosing spondylitis	0.000126	0.000539	CcSEcCtD
Dasatinib—Headache—Prednisone—ankylosing spondylitis	0.000125	0.000536	CcSEcCtD
Dasatinib—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000123	0.000527	CcSEcCtD
Dasatinib—Asthenia—Methotrexate—ankylosing spondylitis	0.00012	0.000513	CcSEcCtD
Dasatinib—Nausea—Prednisone—ankylosing spondylitis	0.000119	0.000508	CcSEcCtD
Dasatinib—Pruritus—Methotrexate—ankylosing spondylitis	0.000118	0.000506	CcSEcCtD
Dasatinib—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000114	0.000489	CcSEcCtD
Dasatinib—Dizziness—Methotrexate—ankylosing spondylitis	0.000111	0.000473	CcSEcCtD
Dasatinib—Vomiting—Methotrexate—ankylosing spondylitis	0.000106	0.000455	CcSEcCtD
Dasatinib—Rash—Methotrexate—ankylosing spondylitis	0.000105	0.000451	CcSEcCtD
Dasatinib—Dermatitis—Methotrexate—ankylosing spondylitis	0.000105	0.00045	CcSEcCtD
Dasatinib—Headache—Methotrexate—ankylosing spondylitis	0.000105	0.000448	CcSEcCtD
Dasatinib—Nausea—Methotrexate—ankylosing spondylitis	9.93e-05	0.000425	CcSEcCtD
Dasatinib—SRC—Immune System—CARD9—ankylosing spondylitis	6.58e-05	0.00028	CbGpPWpGaD
Dasatinib—YES1—Innate Immune System—TLR4—ankylosing spondylitis	6.58e-05	0.00028	CbGpPWpGaD
Dasatinib—PDGFRA—Innate Immune System—HLA-B—ankylosing spondylitis	6.56e-05	0.000279	CbGpPWpGaD
Dasatinib—HCK—Immune System—IL1A—ankylosing spondylitis	6.56e-05	0.000279	CbGpPWpGaD
Dasatinib—HCK—Immune System—CD40LG—ankylosing spondylitis	6.52e-05	0.000277	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—HLA-C—ankylosing spondylitis	6.46e-05	0.000275	CbGpPWpGaD
Dasatinib—MAP3K3—Immune System—HLA-A—ankylosing spondylitis	6.44e-05	0.000274	CbGpPWpGaD
Dasatinib—PDGFRA—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	6.36e-05	0.00027	CbGpPWpGaD
Dasatinib—PDGFRB—MAPK Signaling Pathway—TNF—ankylosing spondylitis	6.34e-05	0.00027	CbGpPWpGaD
Dasatinib—PDGFRA—Adaptive Immune System—HLA-B—ankylosing spondylitis	6.3e-05	0.000268	CbGpPWpGaD
Dasatinib—BTK—Immune System—HLA-A—ankylosing spondylitis	6.26e-05	0.000266	CbGpPWpGaD
Dasatinib—HCK—Immune System—HLA-B—ankylosing spondylitis	6.2e-05	0.000264	CbGpPWpGaD
Dasatinib—RIPK2—Immune System—IL1A—ankylosing spondylitis	6.17e-05	0.000263	CbGpPWpGaD
Dasatinib—KIT—Adaptive Immune System—HLA-A—ankylosing spondylitis	6.16e-05	0.000262	CbGpPWpGaD
Dasatinib—RIPK2—Immune System—CD40LG—ankylosing spondylitis	6.14e-05	0.000261	CbGpPWpGaD
Dasatinib—MAP3K3—Immune System—CRP—ankylosing spondylitis	6.14e-05	0.000261	CbGpPWpGaD
Dasatinib—KIT—Innate Immune System—CRP—ankylosing spondylitis	6.12e-05	0.000261	CbGpPWpGaD
Dasatinib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—ankylosing spondylitis	6e-05	0.000255	CbGpPWpGaD
Dasatinib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—ankylosing spondylitis	6e-05	0.000255	CbGpPWpGaD
Dasatinib—BTK—Immune System—CRP—ankylosing spondylitis	5.97e-05	0.000254	CbGpPWpGaD
Dasatinib—JAK2—GPCR downstream signaling—PTGER4—ankylosing spondylitis	5.97e-05	0.000254	CbGpPWpGaD
Dasatinib—PDGFRB—Adaptive Immune System—CD40LG—ankylosing spondylitis	5.97e-05	0.000254	CbGpPWpGaD
Dasatinib—BLK—Immune System—IL1A—ankylosing spondylitis	5.94e-05	0.000253	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—PTGER4—ankylosing spondylitis	5.93e-05	0.000252	CbGpPWpGaD
Dasatinib—KIT—Immune System—IL1RN—ankylosing spondylitis	5.93e-05	0.000252	CbGpPWpGaD
Dasatinib—FGR—Immune System—IL1A—ankylosing spondylitis	5.92e-05	0.000252	CbGpPWpGaD
Dasatinib—PDGFRB—Innate Immune System—HLA-B—ankylosing spondylitis	5.91e-05	0.000251	CbGpPWpGaD
Dasatinib—BLK—Immune System—CD40LG—ankylosing spondylitis	5.91e-05	0.000251	CbGpPWpGaD
Dasatinib—MAPK14—MAPK Signaling Pathway—TNF—ankylosing spondylitis	5.89e-05	0.000251	CbGpPWpGaD
Dasatinib—MAP3K3—Immune System—TLR4—ankylosing spondylitis	5.89e-05	0.00025	CbGpPWpGaD
Dasatinib—FGR—Immune System—CD40LG—ankylosing spondylitis	5.89e-05	0.00025	CbGpPWpGaD
Dasatinib—LCK—Adaptive Immune System—CD79A—ankylosing spondylitis	5.87e-05	0.00025	CbGpPWpGaD
Dasatinib—KIT—Innate Immune System—TLR4—ankylosing spondylitis	5.87e-05	0.00025	CbGpPWpGaD
Dasatinib—LYN—Adaptive Immune System—CD40LG—ankylosing spondylitis	5.84e-05	0.000249	CbGpPWpGaD
Dasatinib—RIPK2—Immune System—HLA-B—ankylosing spondylitis	5.84e-05	0.000249	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—MMP3—ankylosing spondylitis	5.84e-05	0.000249	CbGpPWpGaD
Dasatinib—LCK—Disease—B3GNT2—ankylosing spondylitis	5.84e-05	0.000248	CbGpPWpGaD
Dasatinib—PDGFRA—Adaptive Immune System—HLA-A—ankylosing spondylitis	5.84e-05	0.000248	CbGpPWpGaD
Dasatinib—YES1—Immune System—CD79A—ankylosing spondylitis	5.83e-05	0.000248	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—HLA-C—ankylosing spondylitis	5.82e-05	0.000248	CbGpPWpGaD
Dasatinib—PDGFRA—Innate Immune System—CRP—ankylosing spondylitis	5.8e-05	0.000247	CbGpPWpGaD
Dasatinib—LYN—Innate Immune System—HLA-B—ankylosing spondylitis	5.79e-05	0.000246	CbGpPWpGaD
Dasatinib—ABL1—Innate Immune System—HLA-B—ankylosing spondylitis	5.76e-05	0.000245	CbGpPWpGaD
Dasatinib—FYN—Adaptive Immune System—CD40LG—ankylosing spondylitis	5.75e-05	0.000245	CbGpPWpGaD
Dasatinib—EPHA2—Developmental Biology—TNF—ankylosing spondylitis	5.75e-05	0.000245	CbGpPWpGaD
Dasatinib—HCK—Immune System—HLA-A—ankylosing spondylitis	5.74e-05	0.000244	CbGpPWpGaD
Dasatinib—BTK—Immune System—TLR4—ankylosing spondylitis	5.73e-05	0.000244	CbGpPWpGaD
Dasatinib—LYN—Immune System—HLA-C—ankylosing spondylitis	5.7e-05	0.000243	CbGpPWpGaD
Dasatinib—FYN—Innate Immune System—HLA-B—ankylosing spondylitis	5.7e-05	0.000242	CbGpPWpGaD
Dasatinib—PDGFRB—Adaptive Immune System—HLA-B—ankylosing spondylitis	5.67e-05	0.000241	CbGpPWpGaD
Dasatinib—ABL1—Immune System—HLA-C—ankylosing spondylitis	5.67e-05	0.000241	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—MMP3—ankylosing spondylitis	5.66e-05	0.000241	CbGpPWpGaD
Dasatinib—BLK—Immune System—HLA-B—ankylosing spondylitis	5.62e-05	0.000239	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—IL1RN—ankylosing spondylitis	5.61e-05	0.000239	CbGpPWpGaD
Dasatinib—FYN—Immune System—HLA-C—ankylosing spondylitis	5.61e-05	0.000239	CbGpPWpGaD
Dasatinib—FGR—Immune System—HLA-B—ankylosing spondylitis	5.6e-05	0.000238	CbGpPWpGaD
Dasatinib—ABL1—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	5.58e-05	0.000237	CbGpPWpGaD
Dasatinib—PDGFRA—Innate Immune System—TLR4—ankylosing spondylitis	5.56e-05	0.000237	CbGpPWpGaD
Dasatinib—LYN—Adaptive Immune System—HLA-B—ankylosing spondylitis	5.56e-05	0.000236	CbGpPWpGaD
Dasatinib—MAPK14—Innate Immune System—HLA-B—ankylosing spondylitis	5.48e-05	0.000233	CbGpPWpGaD
Dasatinib—HCK—Immune System—CRP—ankylosing spondylitis	5.48e-05	0.000233	CbGpPWpGaD
Dasatinib—FYN—Adaptive Immune System—HLA-B—ankylosing spondylitis	5.47e-05	0.000233	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—IL1A—ankylosing spondylitis	5.44e-05	0.000232	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—PTGER4—ankylosing spondylitis	5.42e-05	0.000231	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—PTGER4—ankylosing spondylitis	5.42e-05	0.000231	CbGpPWpGaD
Dasatinib—JAK2—Innate Immune System—HLA-B—ankylosing spondylitis	5.41e-05	0.00023	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—CD40LG—ankylosing spondylitis	5.41e-05	0.00023	CbGpPWpGaD
Dasatinib—RIPK2—Immune System—HLA-A—ankylosing spondylitis	5.41e-05	0.00023	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—HLA-C—ankylosing spondylitis	5.4e-05	0.00023	CbGpPWpGaD
Dasatinib—JAK2—Immune System—HLA-C—ankylosing spondylitis	5.33e-05	0.000227	CbGpPWpGaD
Dasatinib—MAPK14—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	5.31e-05	0.000226	CbGpPWpGaD
Dasatinib—HCK—Disease—HLA-A—ankylosing spondylitis	5.3e-05	0.000226	CbGpPWpGaD
Dasatinib—PDGFRB—Adaptive Immune System—HLA-A—ankylosing spondylitis	5.26e-05	0.000224	CbGpPWpGaD
Dasatinib—HCK—Immune System—TLR4—ankylosing spondylitis	5.25e-05	0.000224	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—PTGER4—ankylosing spondylitis	5.23e-05	0.000222	CbGpPWpGaD
Dasatinib—PDGFRB—Innate Immune System—CRP—ankylosing spondylitis	5.22e-05	0.000222	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—B3GNT2—ankylosing spondylitis	5.21e-05	0.000222	CbGpPWpGaD
Dasatinib—KIT—Immune System—CD79A—ankylosing spondylitis	5.2e-05	0.000222	CbGpPWpGaD
Dasatinib—BLK—Immune System—HLA-A—ankylosing spondylitis	5.2e-05	0.000222	CbGpPWpGaD
Dasatinib—SRC—Adaptive Immune System—CD79A—ankylosing spondylitis	5.2e-05	0.000221	CbGpPWpGaD
Dasatinib—FGR—Immune System—HLA-A—ankylosing spondylitis	5.19e-05	0.000221	CbGpPWpGaD
Dasatinib—SRC—Disease—B3GNT2—ankylosing spondylitis	5.17e-05	0.00022	CbGpPWpGaD
Dasatinib—RIPK2—Immune System—CRP—ankylosing spondylitis	5.16e-05	0.00022	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—HLA-B—ankylosing spondylitis	5.15e-05	0.000219	CbGpPWpGaD
Dasatinib—LYN—Adaptive Immune System—HLA-A—ankylosing spondylitis	5.15e-05	0.000219	CbGpPWpGaD
Dasatinib—LYN—Innate Immune System—CRP—ankylosing spondylitis	5.11e-05	0.000218	CbGpPWpGaD
Dasatinib—ABL1—Innate Immune System—CRP—ankylosing spondylitis	5.09e-05	0.000217	CbGpPWpGaD
Dasatinib—FYN—Adaptive Immune System—HLA-A—ankylosing spondylitis	5.07e-05	0.000216	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—IL1RN—ankylosing spondylitis	5.06e-05	0.000215	CbGpPWpGaD
Dasatinib—FYN—Innate Immune System—CRP—ankylosing spondylitis	5.03e-05	0.000214	CbGpPWpGaD
Dasatinib—PDGFRB—Innate Immune System—TLR4—ankylosing spondylitis	5.01e-05	0.000213	CbGpPWpGaD
Dasatinib—BLK—Immune System—CRP—ankylosing spondylitis	4.97e-05	0.000211	CbGpPWpGaD
Dasatinib—LYN—Immune System—IL1RN—ankylosing spondylitis	4.95e-05	0.000211	CbGpPWpGaD
Dasatinib—RIPK2—Immune System—TLR4—ankylosing spondylitis	4.95e-05	0.000211	CbGpPWpGaD
Dasatinib—FGR—Immune System—CRP—ankylosing spondylitis	4.95e-05	0.000211	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—CD79A—ankylosing spondylitis	4.93e-05	0.00021	CbGpPWpGaD
Dasatinib—ABL1—Immune System—IL1RN—ankylosing spondylitis	4.93e-05	0.00021	CbGpPWpGaD
Dasatinib—LYN—Innate Immune System—TLR4—ankylosing spondylitis	4.9e-05	0.000209	CbGpPWpGaD
Dasatinib—ABL1—Innate Immune System—TLR4—ankylosing spondylitis	4.88e-05	0.000208	CbGpPWpGaD
Dasatinib—ABCB1—Allograft Rejection—TNF—ankylosing spondylitis	4.88e-05	0.000208	CbGpPWpGaD
Dasatinib—FYN—Immune System—IL1RN—ankylosing spondylitis	4.87e-05	0.000207	CbGpPWpGaD
Dasatinib—MAPK14—Innate Immune System—CRP—ankylosing spondylitis	4.85e-05	0.000206	CbGpPWpGaD
Dasatinib—FYN—Innate Immune System—TLR4—ankylosing spondylitis	4.83e-05	0.000205	CbGpPWpGaD
Dasatinib—LCK—Adaptive Immune System—CD40LG—ankylosing spondylitis	4.79e-05	0.000204	CbGpPWpGaD
Dasatinib—JAK2—Innate Immune System—CRP—ankylosing spondylitis	4.79e-05	0.000204	CbGpPWpGaD
Dasatinib—YES1—Immune System—IL1A—ankylosing spondylitis	4.78e-05	0.000203	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—HLA-A—ankylosing spondylitis	4.77e-05	0.000203	CbGpPWpGaD
Dasatinib—BLK—Immune System—TLR4—ankylosing spondylitis	4.76e-05	0.000203	CbGpPWpGaD
Dasatinib—YES1—Immune System—CD40LG—ankylosing spondylitis	4.75e-05	0.000202	CbGpPWpGaD
Dasatinib—FGR—Immune System—TLR4—ankylosing spondylitis	4.74e-05	0.000202	CbGpPWpGaD
Dasatinib—LCK—Innate Immune System—HLA-B—ankylosing spondylitis	4.74e-05	0.000202	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—B3GNT2—ankylosing spondylitis	4.74e-05	0.000202	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—IL1RN—ankylosing spondylitis	4.69e-05	0.0002	CbGpPWpGaD
Dasatinib—LCK—Immune System—HLA-C—ankylosing spondylitis	4.67e-05	0.000199	CbGpPWpGaD
Dasatinib—MAPK14—Innate Immune System—TLR4—ankylosing spondylitis	4.65e-05	0.000198	CbGpPWpGaD
Dasatinib—JAK2—Immune System—IL1RN—ankylosing spondylitis	4.63e-05	0.000197	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—PTGER4—ankylosing spondylitis	4.59e-05	0.000195	CbGpPWpGaD
Dasatinib—JAK2—Innate Immune System—TLR4—ankylosing spondylitis	4.59e-05	0.000195	CbGpPWpGaD
Dasatinib—LCK—Adaptive Immune System—HLA-B—ankylosing spondylitis	4.55e-05	0.000194	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—CRP—ankylosing spondylitis	4.55e-05	0.000194	CbGpPWpGaD
Dasatinib—YES1—Immune System—HLA-B—ankylosing spondylitis	4.52e-05	0.000192	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—CD79A—ankylosing spondylitis	4.44e-05	0.000189	CbGpPWpGaD
Dasatinib—ERBB3—Disease—HLA-A—ankylosing spondylitis	4.4e-05	0.000187	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—TLR4—ankylosing spondylitis	4.36e-05	0.000186	CbGpPWpGaD
Dasatinib—LYN—Immune System—CD79A—ankylosing spondylitis	4.35e-05	0.000185	CbGpPWpGaD
Dasatinib—ABL1—Immune System—CD79A—ankylosing spondylitis	4.33e-05	0.000184	CbGpPWpGaD
Dasatinib—FYN—Immune System—CD79A—ankylosing spondylitis	4.28e-05	0.000182	CbGpPWpGaD
Dasatinib—KIT—Immune System—IL1A—ankylosing spondylitis	4.27e-05	0.000182	CbGpPWpGaD
Dasatinib—KIT—Immune System—CD40LG—ankylosing spondylitis	4.24e-05	0.000181	CbGpPWpGaD
Dasatinib—SRC—Adaptive Immune System—CD40LG—ankylosing spondylitis	4.24e-05	0.00018	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—MMP3—ankylosing spondylitis	4.22e-05	0.00018	CbGpPWpGaD
Dasatinib—LCK—Adaptive Immune System—HLA-A—ankylosing spondylitis	4.22e-05	0.00018	CbGpPWpGaD
Dasatinib—SRC—Innate Immune System—HLA-B—ankylosing spondylitis	4.2e-05	0.000179	CbGpPWpGaD
Dasatinib—LCK—Innate Immune System—CRP—ankylosing spondylitis	4.19e-05	0.000178	CbGpPWpGaD
Dasatinib—YES1—Immune System—HLA-A—ankylosing spondylitis	4.19e-05	0.000178	CbGpPWpGaD
Dasatinib—SRC—Immune System—HLA-C—ankylosing spondylitis	4.13e-05	0.000176	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—CD79A—ankylosing spondylitis	4.12e-05	0.000175	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—PTGER4—ankylosing spondylitis	4.1e-05	0.000174	CbGpPWpGaD
Dasatinib—SRC—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	4.07e-05	0.000173	CbGpPWpGaD
Dasatinib—JAK2—Immune System—CD79A—ankylosing spondylitis	4.07e-05	0.000173	CbGpPWpGaD
Dasatinib—LCK—Immune System—IL1RN—ankylosing spondylitis	4.06e-05	0.000173	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—IL1A—ankylosing spondylitis	4.04e-05	0.000172	CbGpPWpGaD
Dasatinib—KIT—Immune System—HLA-B—ankylosing spondylitis	4.04e-05	0.000172	CbGpPWpGaD
Dasatinib—SRC—Adaptive Immune System—HLA-B—ankylosing spondylitis	4.03e-05	0.000172	CbGpPWpGaD
Dasatinib—LCK—Innate Immune System—TLR4—ankylosing spondylitis	4.02e-05	0.000171	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—CD40LG—ankylosing spondylitis	4.02e-05	0.000171	CbGpPWpGaD
Dasatinib—YES1—Immune System—CRP—ankylosing spondylitis	3.99e-05	0.00017	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—PTGER4—ankylosing spondylitis	3.88e-05	0.000165	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—MMP3—ankylosing spondylitis	3.86e-05	0.000164	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—MMP3—ankylosing spondylitis	3.86e-05	0.000164	CbGpPWpGaD
Dasatinib—YES1—Immune System—TLR4—ankylosing spondylitis	3.83e-05	0.000163	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—HLA-B—ankylosing spondylitis	3.82e-05	0.000163	CbGpPWpGaD
Dasatinib—KIT—Immune System—HLA-A—ankylosing spondylitis	3.74e-05	0.000159	CbGpPWpGaD
Dasatinib—SRC—Adaptive Immune System—HLA-A—ankylosing spondylitis	3.74e-05	0.000159	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—MMP3—ankylosing spondylitis	3.72e-05	0.000158	CbGpPWpGaD
Dasatinib—SRC—Innate Immune System—CRP—ankylosing spondylitis	3.71e-05	0.000158	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—IL1A—ankylosing spondylitis	3.64e-05	0.000155	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—CD40LG—ankylosing spondylitis	3.62e-05	0.000154	CbGpPWpGaD
Dasatinib—SRC—Immune System—IL1RN—ankylosing spondylitis	3.59e-05	0.000153	CbGpPWpGaD
Dasatinib—KIT—Immune System—CRP—ankylosing spondylitis	3.57e-05	0.000152	CbGpPWpGaD
Dasatinib—LYN—Immune System—IL1A—ankylosing spondylitis	3.56e-05	0.000152	CbGpPWpGaD
Dasatinib—LCK—Immune System—CD79A—ankylosing spondylitis	3.56e-05	0.000152	CbGpPWpGaD
Dasatinib—SRC—Innate Immune System—TLR4—ankylosing spondylitis	3.56e-05	0.000151	CbGpPWpGaD
Dasatinib—ABL1—Immune System—IL1A—ankylosing spondylitis	3.55e-05	0.000151	CbGpPWpGaD
Dasatinib—LYN—Immune System—CD40LG—ankylosing spondylitis	3.54e-05	0.000151	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—HLA-A—ankylosing spondylitis	3.54e-05	0.000151	CbGpPWpGaD
Dasatinib—ABL1—Immune System—CD40LG—ankylosing spondylitis	3.53e-05	0.00015	CbGpPWpGaD
Dasatinib—YES1—Developmental Biology—TNF—ankylosing spondylitis	3.52e-05	0.00015	CbGpPWpGaD
Dasatinib—FYN—Immune System—IL1A—ankylosing spondylitis	3.51e-05	0.000149	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—PTGER4—ankylosing spondylitis	3.49e-05	0.000149	CbGpPWpGaD
Dasatinib—FYN—Immune System—CD40LG—ankylosing spondylitis	3.49e-05	0.000148	CbGpPWpGaD
Dasatinib—KIT—Disease—HLA-A—ankylosing spondylitis	3.45e-05	0.000147	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—HLA-B—ankylosing spondylitis	3.44e-05	0.000146	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—PTGER4—ankylosing spondylitis	3.42e-05	0.000146	CbGpPWpGaD
Dasatinib—KIT—Immune System—TLR4—ankylosing spondylitis	3.42e-05	0.000146	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—B3GNT2—ankylosing spondylitis	3.39e-05	0.000144	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—IL1A—ankylosing spondylitis	3.38e-05	0.000144	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—CRP—ankylosing spondylitis	3.38e-05	0.000144	CbGpPWpGaD
Dasatinib—LYN—Immune System—HLA-B—ankylosing spondylitis	3.37e-05	0.000143	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—PTGER4—ankylosing spondylitis	3.37e-05	0.000143	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—CD40LG—ankylosing spondylitis	3.36e-05	0.000143	CbGpPWpGaD
Dasatinib—ABL1—Immune System—HLA-B—ankylosing spondylitis	3.35e-05	0.000143	CbGpPWpGaD
Dasatinib—JAK2—Immune System—IL1A—ankylosing spondylitis	3.33e-05	0.000142	CbGpPWpGaD
Dasatinib—FYN—Immune System—HLA-B—ankylosing spondylitis	3.32e-05	0.000141	CbGpPWpGaD
Dasatinib—JAK2—Immune System—CD40LG—ankylosing spondylitis	3.32e-05	0.000141	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—HLA-A—ankylosing spondylitis	3.27e-05	0.000139	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—MMP3—ankylosing spondylitis	3.27e-05	0.000139	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—PTGER4—ankylosing spondylitis	3.24e-05	0.000138	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—TLR4—ankylosing spondylitis	3.24e-05	0.000138	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—B3GNT2—ankylosing spondylitis	3.21e-05	0.000136	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—PTGER4—ankylosing spondylitis	3.2e-05	0.000136	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—HLA-B—ankylosing spondylitis	3.19e-05	0.000136	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—HLA-A—ankylosing spondylitis	3.19e-05	0.000136	CbGpPWpGaD
Dasatinib—JAK2—Immune System—HLA-B—ankylosing spondylitis	3.15e-05	0.000134	CbGpPWpGaD
Dasatinib—SRC—Immune System—CD79A—ankylosing spondylitis	3.15e-05	0.000134	CbGpPWpGaD
Dasatinib—LYN—Immune System—HLA-A—ankylosing spondylitis	3.12e-05	0.000133	CbGpPWpGaD
Dasatinib—ABL1—Immune System—HLA-A—ankylosing spondylitis	3.11e-05	0.000132	CbGpPWpGaD
Dasatinib—FYN—Immune System—HLA-A—ankylosing spondylitis	3.07e-05	0.000131	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—CRP—ankylosing spondylitis	3.04e-05	0.000129	CbGpPWpGaD
Dasatinib—LYN—Immune System—CRP—ankylosing spondylitis	2.98e-05	0.000127	CbGpPWpGaD
Dasatinib—ABL1—Immune System—CRP—ankylosing spondylitis	2.96e-05	0.000126	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—HLA-A—ankylosing spondylitis	2.96e-05	0.000126	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—HLA-A—ankylosing spondylitis	2.94e-05	0.000125	CbGpPWpGaD
Dasatinib—FYN—Immune System—CRP—ankylosing spondylitis	2.93e-05	0.000125	CbGpPWpGaD
Dasatinib—JAK2—Immune System—HLA-A—ankylosing spondylitis	2.92e-05	0.000124	CbGpPWpGaD
Dasatinib—LCK—Immune System—IL1A—ankylosing spondylitis	2.92e-05	0.000124	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—MMP3—ankylosing spondylitis	2.92e-05	0.000124	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—TLR4—ankylosing spondylitis	2.92e-05	0.000124	CbGpPWpGaD
Dasatinib—LCK—Immune System—CD40LG—ankylosing spondylitis	2.9e-05	0.000124	CbGpPWpGaD
Dasatinib—LYN—Immune System—TLR4—ankylosing spondylitis	2.86e-05	0.000122	CbGpPWpGaD
Dasatinib—ABL1—Immune System—TLR4—ankylosing spondylitis	2.84e-05	0.000121	CbGpPWpGaD
Dasatinib—FYN—Disease—HLA-A—ankylosing spondylitis	2.84e-05	0.000121	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—CRP—ankylosing spondylitis	2.82e-05	0.00012	CbGpPWpGaD
Dasatinib—FYN—Immune System—TLR4—ankylosing spondylitis	2.81e-05	0.00012	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—PTGER4—ankylosing spondylitis	2.8e-05	0.000119	CbGpPWpGaD
Dasatinib—JAK2—Immune System—CRP—ankylosing spondylitis	2.79e-05	0.000119	CbGpPWpGaD
Dasatinib—LCK—Immune System—HLA-B—ankylosing spondylitis	2.76e-05	0.000118	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—MMP3—ankylosing spondylitis	2.76e-05	0.000118	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—TLR4—ankylosing spondylitis	2.71e-05	0.000115	CbGpPWpGaD
Dasatinib—JAK2—Disease—HLA-A—ankylosing spondylitis	2.7e-05	0.000115	CbGpPWpGaD
Dasatinib—JAK2—Immune System—TLR4—ankylosing spondylitis	2.67e-05	0.000114	CbGpPWpGaD
Dasatinib—LYN—Developmental Biology—TNF—ankylosing spondylitis	2.62e-05	0.000112	CbGpPWpGaD
Dasatinib—ABL1—Developmental Biology—TNF—ankylosing spondylitis	2.61e-05	0.000111	CbGpPWpGaD
Dasatinib—SRC—Immune System—IL1A—ankylosing spondylitis	2.59e-05	0.00011	CbGpPWpGaD
Dasatinib—FYN—Developmental Biology—TNF—ankylosing spondylitis	2.58e-05	0.00011	CbGpPWpGaD
Dasatinib—SRC—Immune System—CD40LG—ankylosing spondylitis	2.57e-05	0.000109	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—B3GNT2—ankylosing spondylitis	2.56e-05	0.000109	CbGpPWpGaD
Dasatinib—LCK—Immune System—HLA-A—ankylosing spondylitis	2.56e-05	0.000109	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—MMP3—ankylosing spondylitis	2.49e-05	0.000106	CbGpPWpGaD
Dasatinib—MAPK14—Developmental Biology—TNF—ankylosing spondylitis	2.48e-05	0.000106	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—PTGER4—ankylosing spondylitis	2.48e-05	0.000106	CbGpPWpGaD
Dasatinib—JAK2—Developmental Biology—TNF—ankylosing spondylitis	2.45e-05	0.000104	CbGpPWpGaD
Dasatinib—SRC—Immune System—HLA-B—ankylosing spondylitis	2.45e-05	0.000104	CbGpPWpGaD
Dasatinib—LCK—Immune System—CRP—ankylosing spondylitis	2.44e-05	0.000104	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—MMP3—ankylosing spondylitis	2.44e-05	0.000104	CbGpPWpGaD
Dasatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	2.41e-05	0.000102	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—MMP3—ankylosing spondylitis	2.4e-05	0.000102	CbGpPWpGaD
Dasatinib—LCK—Disease—HLA-A—ankylosing spondylitis	2.36e-05	0.000101	CbGpPWpGaD
Dasatinib—LCK—Immune System—TLR4—ankylosing spondylitis	2.34e-05	9.96e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—MMP3—ankylosing spondylitis	2.31e-05	9.83e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—MMP3—ankylosing spondylitis	2.28e-05	9.7e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—HLA-A—ankylosing spondylitis	2.27e-05	9.64e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—CRP—ankylosing spondylitis	2.16e-05	9.2e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—HLA-A—ankylosing spondylitis	2.09e-05	8.9e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—TLR4—ankylosing spondylitis	2.07e-05	8.82e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—B3GNT2—ankylosing spondylitis	2.04e-05	8.7e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—MMP3—ankylosing spondylitis	2e-05	8.5e-05	CbGpPWpGaD
Dasatinib—SRC—Developmental Biology—TNF—ankylosing spondylitis	1.9e-05	8.09e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—MMP3—ankylosing spondylitis	1.77e-05	7.52e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—B3GNT2—ankylosing spondylitis	1.58e-05	6.72e-05	CbGpPWpGaD
